Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1991007984) TREATMENT OF ATOPIC DISORDERS WITH GAMMA-INTERFERON
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1991/007984 International Application No.: PCT/US1990/006971
Publication Date: 13.06.1991 International Filing Date: 29.11.1990
Chapter 2 Demand Filed: 27.06.1991
IPC:
A61K 38/21 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
19
Cytokines; Lymphokines; Interferons
21
Interferons
Applicants:
CHILDREN'S MEDICAL CENTER CORPORATION [US/US]; 300 Longwood Avenue Boston, MA 02115, US
Inventors:
LEUNG, Donald, Y., M.; US
GEHA, Raif, S.; US
Agent:
BROOK, David, E. ; Hamilton, Brook, Smith & Reynolds Two Militia Drive Lexington, MA 02173, US
Priority Data:
444,76301.12.1989US
Title (EN) TREATMENT OF ATOPIC DISORDERS WITH GAMMA-INTERFERON
(FR) TRAITEMENT DE TROUBLES ATOPIQUES A L'AIDE D'INTERFERON GAMMA
Abstract:
(EN) A method of treating patients having chronic, severe allergic disorders, such as atopic dermatitis or steroid-dependent asthma, with gamma interferon is disclosed. The method involves treating patients afflicted with atopic dermatitis or steroïd-dependent asthma with effective dosages of gamma interferon, which reduces the clinical severity of their disease.
(FR) Procédé de traitement de patients présentant des troubles allergiques chroniques graves, tels que l'eczéma constitutionnel ou l'asthme liée à des stéroïdes, à l'aide d'interféron gamma. Le procédé consiste à traiter des patients souffrant d'eczéma constitutionnel ou d'asthme liée à des stéroïdes, à l'aide de dosages efficaces d'interférons gamma, ce qui réduit la gravité clinique de leur maladie.
Designated States: CA, JP
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0502997JPH05501716CA2069870